Prostate cancer is one of the most widespread types of cancer in men and its cure was limited to surgery for confined state and androgen ablation for advanced disease until new alternatives became accessible. This book talks about a broad spectrum of current research on appropriate cell biology and focuses in detail on supportive modalities for prostate cancer patients, adequate selection of new therapeutic regimens, inclusive of inhibitors of steroidal synthesis, cytotoxic agents as well as intermittent androgen suppression and the functions of prostate cancer stem cells and inflammatory processes.